7
Volume 8, Number 5, September 2021 Neurology.org/NN A peer-reviewed clinical and translational neurology open access journal ARTICLE Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation e1029 ARTICLE Autoimmune Encephalitis Resembling Dementia Syndromes e1039 ARTICLE International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis e1052 ARTICLE COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry e1057

LWW NEURIMMINFL NEURIMMINFLcover 8 5

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: LWW NEURIMMINFL NEURIMMINFLcover 8 5

Volume 8, Number 5, September 2021Neurology.org/NN

A peer-reviewed clinical and translational neurology open access journal

ARTICLE

Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinfl ammation e1029

ARTICLE

Autoimmune Encephalitis Resembling Dementia Syndromes e1039

ARTICLE

International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis e1052

ARTICLE

COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry e1057

Page 2: LWW NEURIMMINFL NEURIMMINFLcover 8 5

Academy OfficersOrly Avitzur, MD, MBA, FAAN, PresidentCarlayne E. Jackson, MD, FAAN, President ElectJanis M. Miyasaki, MD, MEd, FRCPC, FAAN, Vice PresidentSarah M. Benish, MD, FAAN, SecretaryCharles C. Flippen II, MD, FAAN, TreasurerJames C. Stevens, MD, FAAN, Past President

CEO, American Academy of NeurologyMary E. Post, MBA, CAEChief Executive Officer201 Chicago AveMinneapolis, MN 55415Tel: 612-928-6100

Editorial OfficePatricia K. Baskin, MS, Executive EditorRachel A. Anderson, Administrative Assistant

Adria Gottesman-Davis, PhD, Journal Editorial Manager

Morgan S. Sorenson, Managing EditorNeurology® Neuroimmunology & NeuroinflammationNeurology® Genetics

Kathleen M. Pieper, Senior Managing Editor, Neurology®Karen Skaja, Senior Editorial CoordinatorSkyler M. Kane, Editorial CoordinatorMargaret A. Rei, Editorial Coordinator

Lee Ann Kleffman, Managing Editor, Neurology® Clinical Practice

Andrea Rahkola, ELS, Production EditorKristen Swendsrud, Production CoordinatorAubrey Zalewski, Production Coordinator

Sharon L. Quimby, Digital Managing EditorBrooke Eikenberry, Digital Marketing Communications AdministratorKaitlyn Aman Ramm, Digital Multimedia/Graphics CoordinatorHaley McNiff, Digital Multimedia/Podcast Coordinator

PublisherWolters KluwerBaltimore, MD

Publishing StaffSarah Carrera, MBA, Executive PublisherJessica Heise, Production Team Leader, Neurology JournalsEmily Moore, Production EditorStacy Drossner, Production Associate

Neurology® is a registered trademark of the American Academy of Neurology(registration valid in the United States).

Neurology® Neuroimmunology & Neuroinflammation (eISSN 2332-7812) is anopen access journal published online for the American Academy of Neurology,201 Chicago Ave, Minneapolis, MN 55415, by Wolters Kluwer Health, Inc. at14700 Citicorp Drive, Bldg 3, Hagerstown, MD 21742. Business offices arelocated at Two Commerce Square, 2001 Market St., Philadelphia, PA 19103.Production offices are located at 351 West Camden Street, Baltimore, MD21201-2436. © 2021 American Academy of Neurology.

Neurology® Neuroimmunology & Neuroinflammation is an official journal of theAmerican Academy of Neurology. Journal website: Neurology.org/NN, AANwebsite: AAN.com

Copyright and Permission Information: Please go to the journal website(www.neurology.org/nn) and click the Permissions tab for the relevant article.Alternatively, send an email to [email protected]. Generalinformation about permissions can be found here: https://www.lww.com/journal-permission.

Disclaimer: Opinions expressed by the authors and advertisers are notnecessarily those of the American Academy of Neurology, its affiliates, or ofthe Publisher. The American Academy of Neurology, its affiliates, and thePublisher disclaim any liability to any party for the accuracy, completeness,efficacy, or availability of the material contained in this publication (includingdrug dosages) or for any damages arising out of the use or non-use of any of thematerial contained in this publication.

Advertising Sales Representatives: Wolters Kluwer, 333 Seventh Avenue, NewYork, NY 10001. Contacts: Eileen Henry, tel: 732-778-2261, fax: 973-215-2485,[email protected] and in Europe: Craig Silver, tel: +44 7855062 550 or e-mail: [email protected].

Careers & Events: Monique McLaughlin, Wolters Kluwer, Two CommerceSquare, 2001 Market Street, Philadelphia, PA 19103, tel: (215)-521- 8468, fax:215-521-8801; [email protected].

Reprints: Meredith Edelman, Commercial Reprint Sales, Wolters Kluwer,Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103, tel:215-356-2721; [email protected]; [email protected].

Special projects: US & Canada: Alan Moore, Wolters Kluwer, Two CommerceSquare, 2001 Market Street, Philadelphia, PA 19103, tel: 215-521-8638,[email protected]. International: Andrew Wible, Senior Manager,Rights, Licensing, and Partnerships, Wolters Kluwer, [email protected].

Page 3: LWW NEURIMMINFL NEURIMMINFLcover 8 5

A peer-reviewed clinical and translational neurology open access journal Neurology.org/NN

Neurology® Neuroimmunology & Neuroinflammation

EditorJosep O. Dalmau, MD, PhD, FAAN

Deputy EditorScott S. Zamvil, MD, PhD, FAAN

Associate EditorsMarinos Dalakas, MD, FAANDennis Kolson, MD, PhDFriedmann Paul, MDRaquel Sanchez-Valle, MD, PhD

Editorial BoardSergio E. Baranzini, PhDSusanne Benseler, MDJeffrey L. Bennett, MD, PhD, FAANSeverine Boillee, PhDRiley M. Bove, MD, MMSCChiara Briani, MDFabienne Brilot, PhDMatthijs C. Brouwer, MD, PhDWolfgang Bruck, MDStacey L. Clardy MD, PhD, FAANDavid B. Clifford, MD, FAANAnne Haney Cross, MDRussell C. Dale, MBChB, MRCP, PhDThomas G. Forsthuber, MDKazuo Fujihara, MDChristian Geis, MDJeffrey M. Gelfand, MD, MAS, FAANSilvia Gines, PhDFrancesc Graus, MD, PhDKerstin Hellwig, MDRomana Hoftberger, MDMatilde Inglese, MD, PhDTakahiro Iizuka, MD

Luisa Klotz, MDKristen M. Krysko, MD, MASAnnette Langer-Gould, MD, PhDFrank Leypoldt, MDJenny Linnoila, MD, PhDErin Longbrake, MD, PhDAndrew McKeon, MDAnne Louise Oaklander, MD PhD,

FAAN, FANAAnne-Katrin Probstel, MDRichard M. Ransohoff, MDAlbert Saiz, MD, PhDJens Schmidt, MD, FEAN, FAANMarianna Spatola, MD, PhDChristine Stadelmann, MDIsrael Steiner, MDLawrence Steinman, MDSilvia N. Tenembaum, MDCharlotte E. Teunissen, PhDMaarten J. Titulaer, MD, PhDAri Waisman, PhDGregory F. Wu, MD, PhD

Neurology® Journals

Editor-in-ChiefJose G. Merino, MD, MPhil, FAAN

Deputy EditorOlga Ciccarelli, MD, PhD, FRCP

Section Editors

BiostatisticsRichard J. Kryscio, PhDSue Leurgans, PhDV. Shane Pankratz, PhD

Classification of Evidence EvaluationsGary S. Gronseth, MD, FAAN

Equity, Diversity, & InclusionRoy H. Hamilton, MD, MS, FAANHolly E. Hinson, MD, MCR, FAAN

PodcastsStacey L. Clardy, MD, PhD, FAANJeffrey B. Ratliff, MD, Deputy Editor

OmbudsmanJonathan W. Mink, MD, PhD, FAAN

Scientific Integrity AdvisorDavid S. Knopman, MD, FAAN

Classification of Evidence Review TeamMelissa J. Armstrong, MDGregory S. Day, MD, MSc, MSCI, FAANJames Dorman, MD, FAAN, FACPRichard M. Dubinsky, MD, MPH, FAANJeffrey J. Fletcher, MD, MScGary M. Franklin, MD, MPH, FAANDavid S. Gloss II, MD, MPH&TMJohn J. Halperin, MD, FAANJason Lazarou, MSc, MDSteven R. Messe, MD, FAANPushpa Narayanaswami, MBBS, DM, FAANSonja Potrebic, MD, PhD, FAANTamara Pringsheim, MD, FRCPC, FAANAlex Rae-Grant, MD

Vision Neurology® Neuroimmunology &Neuroinflammation will be the premierpeer-reviewed journal in the fields ofneuroimmunology and neuroinflammation.

Mission Neurology: Neuroimmunology &Neuroinflammation will provide neurologistsand clinical research scientists withoutstanding peer-reviewed articles, editorials,and reviews to enhance patient care andfacilitate basic and translational research.

EditorialInquiries

Tel: 612-928-6400Toll-free: 800-957-3182 (US)Fax: [email protected]

StayConnected

facebook.com/NeurologyNN

twitter.com/greenjournal

youtube.com/user/NeurologyJournal

instagram.com/aanbrain

Page 4: LWW NEURIMMINFL NEURIMMINFLcover 8 5

TABLE OF CONTENTS Volume 8, Number 5, September 2021 Neurology.org/NN

Editorial

e1054Combined Neurofilament Light and OpticalCoherence Tomography Better PredictsMultiple Sclerosis Disease Activity Than EitherMeasure AloneJ. Kramer, H. Wiendl, S.G. Meuth, and P. Albrecht

Open Access

Articles

e1028 Antiplexin D1 Antibodies Relate to SmallFiber Neuropathy and Induce Neuropathic Painin AnimalsT. Fujii, E.-J. Lee, Y. Miyachi, R. Yamasaki, Y.-M. Lim, K. Iinuma,A. Sakoda, K.-K. Kim, and J.-i. Kira

Open Access

e1027Differential Binding of Autoantibodies toMOG Isoforms in Inflammatory DemyelinatingDiseasesK. Schanda, P. Peschl, M. Lerch, B. Seebacher, S. Mindorf, N. Ritter,M. Probst, H. Hegen, F. Di Pauli, E.-M. Wendel, C. Lechner,M. Baumann, S. Mariotto, S. Ferrari, A. Saiz, M. Farrell, M.I.S. Leite,S.R. Irani, J. Palace, A. Lutterotti, T. Kumpfel, S. Vukusic, R.Marignier,P. Waters, K. Rostasy, T. Berger, C. Probst, R. Hoftberger, andM. Reindl

Open Access

e1022Nodular Pachymeningitis Associated With RelapsingPolychondritis and Crohn Disease Responsive toAdalimumab and PrednisoneS.K. Hutto, M.D. Maher, E.M. Miloslavsky, and N. Venna

Open Access

e1029 Encephalopathies Associated With Severe COVID-19Present Neurovascular Unit Alterations WithoutEvidence for Strong NeuroinflammationR. Bernard-Valnet, S. Perriot, M. Canales, B. Pizzarotti, L. Caranzano,M. Castro-Jimenez, J.-B. Epiney, S. Vijiala, P. Salvioni-Chiabotti,A. Anichini, A. Salerno, K. Jaton, J. Vaucher, M. Perreau, G. Greub,G. Pantaleo, and R.A. Du Pasquier

Open Access

e1030 Effects of Natalizumab Therapy on IntrathecalImmunoglobulin G Production Indicate Targetingof PlasmablastsM. Schluter, E. Oswald, S. Winklmeier, I. Meinl, J. Havla, P. Eichhorn,E. Meinl, and T. Kumpfel

Open Access

e1031 Interleukin 8, a Biomarker to DifferentiateGuillain-Barre Syndrome From CIDPG.Breville,A.M.Lascano,P.Roux-Lombard,N.Vuilleumier,andP.H.Lalive

Open Access

e1032 Argonaute Autoantibodies as Biomarkers inAutoimmune Neurologic DiseasesL.-D.Do,C.P.Moritz, S.Muñiz-Castrillo,A.-L.Pinto,Y. Tholance,S.Brugiere,Y.Coute,O. Stoevesandt,M.J. Taussig, V.Rogemond,A.Vogrig,B. Joubert,K. Ferraud, J.-P. Camdessanche, J.-C. Antoine, and J. Honnorat

Open Access

e1034Molecular Level Characterization of CirculatingAquaporin-4 Antibodies in Neuromyelitis OpticaSpectrum DisorderJ. Li, S.A.Bazzi, F.Schmitz,H.Tanno, J.R.McDaniel,C.-H.Lee,C. Joshi, J.E.Kim,N. Monson, B.M. Greenberg, K. Hedfalk, E. Melamed, and G.C. Ippolito

Open Access

e1035Ocrelizumab Extended Interval Dosing in MultipleSclerosis in Times of COVID-19L. Rolfes, M. Pawlitzki, S. Pfeuffer, C. Nelke, A. Lux, R. Pul,C. Kleinschnitz, K. Kleinschnitz, R. Rogall, K. Pape, S. Bittner, F. Zipp,C. Warnke, Y. Goereci, M. Schroeter, J. Ingwersen, O. Aktas, L. Klotz,T. Ruck, H. Wiendl, and S.G. Meuth

Open Access

e1024 SARS-CoV-2 Infection in Multiple Sclerosis: Resultsof the Spanish Neurology Society RegistryG. Arrambide, M. Llaneza-Gonzalez, L.C.-F. França, V. Meca-Lallana,E.F. Dıaz, I. Moreno-Torres, J.M. Garcıa-Domınguez,G. Ortega-Suero, L. Ayuso-Peralta, M. Gomez-Moreno,J.J. Sotoca-Fernandez, A.B. Caminero-Rodrıguez,L.A. Rodrıguez de Antonio, M. Corujo-Suarez, M.A. Otano-Martınez,F.C. Perez-Miralles, V. Reyes-Garrido, T. Ayuso-Blanco,J.J. Balseiro-Gomez, M. Muñoz-Pasadas, I. Perez-Molina,C. Arnal-Garcıa, A. Domingo-Santos, C. Guijarro-Castro,C. Iñiguez-Martınez, N.T. Lara, F. Castellanos-Pinedo,T. Castillo-Triviño, D.M. Cerdan-Santacruz, A. Perez-Sempere,B.S. Torres, A.A. de Arcaya, E. Costa-Arpın, E. Duran-Ferreras,M. Fragoso-Martınez, M. Gonzalez-Platas, L. Landete Pascual,J. Millan-Pascual, C. Oreja-Guevara, and J.E. Meca-Lallana

Open Access

Cover ImageAutoantibodies of patients bind to CNTN1 in transfected HEK293 cellsand DRG neurons: Immunoreactivity of sera of patients with contactin-1antibodies with dorsal root ganglia neurons. Panel A shows the lack ofreactivity of serum of a healthy control. Panels B-D show the reactivity ofsera of three patients. Stylized by Haley McNiff, Digital Multimedia/Podcast Coordinator.See page e1056

Continued

Page 5: LWW NEURIMMINFL NEURIMMINFLcover 8 5

e1036Dysregulation of the Adaptive ImmuneSystem in Patients With Early-Stage ParkinsonDiseaseZ. Yan, W. Yang, H. Wei, M.N. Dean, D.G. Standaert, G.R. Cutter,E.N. Benveniste, and H. Qin

Open Access

e1037Dimethyl Fumarate Treatment in Patients WithPrimary Progressive Multiple Sclerosis: ARandomized, Controlled TrialH.H Chow, J. Talbot, H. Lundell, C.G Madsen, L. Marstrand, T. Lange,M.R Mahler, S. Buhelt, R.H Hansen, M. Blinkenberg, J.R Christensen,P.S Sørensen, M. Rode von Essen, H.R Siebner, and F. Sellebjerg

Open Access

e1040 Serum Contactin-1 in CIDP: A Cross-SectionalStudyL. Wieske, L. Martın-Aguilar, J. Fehmi, C. Lleixa,M.J.A. Koel-Simmelink, M. Chatterjee, Z. van Lierop, J. Killestein,C. Verhamme, L. Querol, S. Rinaldi, C.E. Teunissen, and F. Eftimov

Open Access

e1043 The Aryl Hydrocarbon Receptor–DependentTGF-α/VEGF-B Ratio Correlates With DiseaseSubtype and Prognosis in Multiple SclerosisA. Cirac, T. Tsaktanis, T. Beyer, M. Linnerbauer, T. Andlauer,V. Grummel, L. Nirschl, L. Loesslein, F.J. Quintana, B. Hemmer, andV. Rothhammer

Open Access

e1045 Paraneoplastic AQP4-IgG–SeropositiveNeuromyelitis Optica Spectrum DisorderAssociated With Teratoma: A Case Report andLiterature ReviewR. Ikeguchi, Y. Shimizu, A. Shimomura, M. Suzuki, K. Shimoji,T. Motohashi, T. Yamamoto, N. Shibata, and K. Kitagawa

Open Access

e1044Obesity in Pediatric-Onset Multiple Sclerosis:A French Cohort StudyP.Milles, G. De Filippo, H.Maurey, T. Tully, and K. Deiva, on behalf ofthe KidBiosep

Open Access

e1046 A New England COVID-19 Registry of PatientsWith CNS Demyelinating Disease: A PilotAnalysisK.M. Money, A. Mahatoo, S. Samaan, P. Anand, U. Baber, M. Bailey,R. Bakshi, A. Bouley, A. Bower, J. Cahill, M. Houtchens, J. Katz,E. Lathi, E. Levit, E.E. Longbrake, M. McAdams, S. Napoli,P. Raibagkar, P. Wade, and J.A. Sloane

Open Access

e1047 Predicting Aggressive Multiple Sclerosis WithIntrathecal IgM Synthesis Among Patients Witha Clinically Isolated SyndromeE. Monreal, S.S. de la Maza, L. Costa-Frossard, P. Walo-Delgado,J. Zamora, J.I. Fernandez-Velasco, N. Villarrubia, M. Espiño,D. Lourido, P. Lapuente, I. Toboso, J.C. Alvarez-Cermeño,J. Masjuan, and L.M. Villar

Open Access

e1052 International Consensus Recommendations for theTreatment of Pediatric NMDAR AntibodyEncephalitisM. Nosadini, T. Thomas, M. Eyre, B. Anlar, T. Armangue,S.M. Benseler, T. Cellucci, K. Deiva, W. Gallentine, G. Gombolay,M.P. Gorman, Y. Hacohen, Y. Jiang, B.C. Lim, E. Muscal,A. Ndondo, R. Neuteboom, K. Rostasy, H. Sakuma, S. Sharma,S.N. Tenembaum, H.A. Van Mater, E. Wells, R. Wickstrom,A.K. Yeshokumar, S.R. Irani, J. Dalmau, M. Lim, andR.C. Dale

Open Access

e1051 Increased Serum Neurofilament Light and ThinGanglion Cell–Inner Plexiform Layer Are AdditiveRisk Factors for Disease Activity in Early MultipleSclerosisT.-Y. Lin, V. Vitkova, S. Asseyer, I.Martorell Serra, S.Motamedi, C. Chien,M. Ditzhaus, A. Papadopoulou, P. Benkert, J. Kuhle, J. Bellmann-Strobl,K. Ruprecht, F. Paul, A.U. Brandt, and H.G. Zimmermann

Open Access Editorial, p. e1054

e1053 Thymoma and Autoimmune Encephalitis: ClinicalManifestations and AntibodiesM. Guasp, J. Landa, E. Martinez-Hernandez, L. Sabater, T. Iizuka,M. Simabukuro, M. Nakamura, M. Kinoshita, M. Kurihara, K. Kaida,J. Bruna, S. Kapetanovic, P. Sanchez, R. Ruiz-Garcıa, L. Naranjo,J. Planaguma, A. Muñoz-Lopetegi, L. Bataller, A. Saiz, J. Dalmau, andF. Graus

Open Access

e1039 Autoimmune Encephalitis Resembling DementiaSyndromesA.E.M. Bastiaansen, R.W. van Steenhoven, M.A.A.M. de Bruijn,Y.S. Crijnen, A. van Sonderen, M.H. van Coevorden-Hameete,M.M. Nuhn, M.M. Verbeek, M.W.J. Schreurs, P.A.E. Sillevis Smitt,J.M. de Vries, F.J. de Jong, and M.J. Titulaer

Open Access

e1056 Anti–contactin-1 Antibodies Affect Surface Expressionand Sodium Currents in Dorsal Root GangliaJ. Gruner, H. Stengel, C. Werner, L. Appeltshauser, C. Sommer,C. Villmann, and K. Doppler

Open Access

e1055 Impact of Disease-Modifying Treatments of MultipleSclerosis on Anti–SARS-CoV-2 Antibodies: AnObservational StudyK. Bigaut, L. Kremer, T. Fabacher, L. Lanotte, M.-C. Fleury,N. Collongues, and J. de Seze

Open Access

e1041Multiple Sclerosis: circRNA Profile Defined RevealsLinks to B-Cell FunctionA.E. Zurawska, M.P. Mycko, I. Selmaj, C.S. Raine, and K.W. Selmaj

Open Access

e1049 Familial History of Autoimmune Disorders AmongPatients With Pediatric Multiple SclerosisB.M. Greenberg, T.C. Casper, S.S. Mar, J.M. Ness, P. Plumb, S. Liang,M. Goyal, B. Weinstock-Guttman, M. Rodriguez, G.S. Aaen,A. Belman, L.F. Barcellos, J.W. Rose, M.P. Gorman, L.A. Benson,M. Candee, T. Chitnis, Y.C. Harris, I.L. Kahn, S. Roalstad, J. Hart,T.E. Lotze, M. Rensel, J.P. Rubin, T.L. Schreiner, J.-M. Tillema,A.T. Waldman, L. Krupp, J. Graves, K. Drake, and E. Waubant

Open Access

TABLE OF CONTENTS Volume 8, Number 5, September 2021 Neurology.org/NN

Page 6: LWW NEURIMMINFL NEURIMMINFLcover 8 5

e1057COVID-19 in Patients With Neuromyelitis OpticaSpectrum Disorders and Myelin OligodendrocyteGlycoprotein Antibody Disease in North America:From the COViMS RegistryS.D. Newsome, A.H. Cross, R.J. Fox, J. Halper, P. Kanellis, B. Bebo,D. Li, G.R. Cutter, K.W. Rammohan, and A. Salter

Open Access

Clinical/Scientific Notes

e1025 AsepticNeutrophilicMeningitisWithHypoglycorrhachiaFollowing a Single Ocrelizumab InfusionS. Cicero, E. Rissanen, K. Carter, H. Nguyen, R. Petit, T.B. Ellerin,R. Dhillon, and T. Singhal

Open Access

e1048CNS Lymphocytic Vasculitis in a YoungWomanWithCOVID-19 InfectionG.M. Timmons, T. Rempe, E.A. Bevins, V. Goodwill, A. Miner,A. Kavanaugh, M. Ritter, and J.S. Graves

Open Access

e1042CombinedTreatmentWith Pembrolizumab andAllogenicBK Virus-Specific T Cells in Progressive MultifocalLeukoencephalopathy: A Case ReportR. Wicklein, S. Heidegger, M. Verbeek, B. Eiz-Vesper,B. Maecker-Kolhoff, J.S. Kirschke, A. Page, T. Korn, B. Hemmer, andM. Deschauer

Open Access

Views & Reviews

e1033 Autoimmune Neurology: The Need forComprehensive CareJ.R. Abbatemarco, S.J. Rodenbeck, G.S. Day, M.J. Titulaer,A.K. Yeshokumar, and S.L. Clardy

Open Access

Diagnostic and Treatment Challenges

e1026 Encephalitis andMyelitis in a YoungWoman:OverlapSyndrome, Thyroiditis, and Occult Tumor Fromthe National Multiple Sclerosis Society CaseConference ProceedingsN.Z. Esfanhani, A. Wundes, T. Varkey, R.P. Lisak, A. Goodman,J. Graves, S.S. Zamvil, E.M. Frohman, T.C. Frohman, andS.D. Newsome

Open Access

Corrections

e1050COVID-19 Among Patients With Multiple Sclerosis:A Systematic Review

e1072 Encephalitis andMyelitis in a YoungWoman:OverlapSyndrome, Thyroiditis, and Occult Tumor Fromthe National Multiple Sclerosis Society CaseConference Proceedings

TABLE OF CONTENTS Volume 8, Number 5, September 2021 Neurology.org/NN

Page 7: LWW NEURIMMINFL NEURIMMINFLcover 8 5

2021;8; Neurol Neuroimmunol Neuroinflamm 8 (5)

This information is current as of January 1, 2021

ServicesUpdated Information &

http://nn.neurology.org/content/8/5.full.htmlincluding high resolution figures, can be found at:

Supplementary Material http://nn.neurology.org/content/suppl/2021/09/02/8.5.DC1

Supplementary material can be found at:

  Permissions & Licensing

http://nn.neurology.org/misc/about.xhtml#permissionsits entirety can be found online at:Information about reproducing this article in parts (figures,tables) or in

  Reprints

http://nn.neurology.org/misc/addir.xhtml#reprintsusInformation about ordering reprints can be found online:

rights reserved. Online ISSN: 2332-7812.Published since April 2014, it is an open-access, online-only, continuous publication journal. Copyright . All

is an official journal of the American Academy of Neurology.Neurol Neuroimmunol Neuroinflamm